Search

Your search keyword '"Rilpivirine -- Product development -- Research"' showing total 1 results
Start Over Descriptor "Rilpivirine -- Product development -- Research" Journal pharmabiz
1 results on '"Rilpivirine -- Product development -- Research"'

1. ViiV Healthcare to present data from largest head-to-head randomised trial for 2-drug regimen Dovato against 3-drug regimen Biktarvy at AIDS 2024

Subjects
Pfizer Inc. -- Product development, Rilpivirine -- Product development -- Research, Health care industry -- Product development, Clinical trials -- Research, AIDS treatment -- Research, AIDS (Disease) -- Research -- Drug therapy -- Prevention, International relief -- United States, Pharmaceutical industry -- Product development, Health care industry, Pharmaceuticals and cosmetics industries, Biktarvy (Medication) -- Research -- Product development, Dovato (Medication) -- Research -- Product development
Abstract

GSK plc announced that ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, will be presenting the largest head-to-head, randomised clinical trial [...]

Published
2024

Catalog

Books, media, physical & digital resources
See catalog results